Reduced progesterone metabolites in human late pregnancy

Physiological Research

Volumn 60, Issue 2, 2011, Pages 225-241

  Hill, M ^a,b   Parizek A ^b   Kancheva, R ^a   Jirasek J E ^b  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

GC MS; Metabolome; Neuroactive steroids; Plasma; Pregnancy

Indexed keywords

EID: 79959255971     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: 10.33549/physiolres.932077     Document Type: Review

References (115)

1. ANTONIPILLAI I, MURPHY BE, 1977: Serum oestrogens and progesterone in mother and infant at delivery. Br J Obstet Gynaecol 84: 179-185.
2. BELELLI D, LAMBERT JJ, PETERS JA, GEE KW, LAN NC, 1996: Modulation of human recombinant GABAA receptors by pregnanediols. europharmacology 35: 1223-1231.
3. BONENFANT M, BLOMQUIST CH, PROVOST PR, DROLET R, D'ASCOLI P, TREMBLAY Y, 2000: Tissue- and sitespecific gene expression of type 2 17beta-hydroxysteroid dehydrogenase: in situ hybridization and specificenzymatic activity studies in human placental endothelial cells of the arterial system. J Clin Endocrinol Metab 85: 4841-4850.
4. BONENFANT M, PROVOST PR, DROLET R, TREMBLAY Y, 2000: Localization of type 1 17beta-hydroxysteroid dehydrogenase mRNA and protein in syncytiotrophoblasts and invasive cytotrophoblasts in the human term villi. J Endocrinol 165: 217-222.
5. BRERETON P, SUZUKI T, SASANO H, LI K, DUARTE C, OBEYESEKERE V, HAESELEER F, PALCZEWSKI K, SMITH I, KOMESAROFF P, KROZOWSKI Z, 2001: Pan1b (17betaHSD11)-enzymatic activity and distribution in the lung. Mol Cell Endocrinol 171: 111-117.
6. BRUSSAARD AB, KITS KS, BAKER RE, WILLEMS WP, LEYTING-VERMEULEN JW, VOORN P, SMIT AB, BICKNELL RJ, HERBISON AE, 1997: Plasticity in fast synaptic inhibition of adult oxytocin neurons caused by switch in GABA(A) receptor subunit expression. Neuron. 19: 1103-1114.
7. BUSTER JE, CHANG RJ, PRESTON DL, ELASHOFF RM, COUSINS LM, ABRAHAM GE, HOBEL CJ, MARSHALL JR, 1979: Interrelationships of circulating maternal steroid concentrations in third trimester pregnancies. II. C18 and C19 steroids: estradiol, estriol, dehydroepiandrosterone, dehydroepiandrosterone sulfate, delta 5-androstenediol, delta 4-androstenedione, testosterone, and dihydrotestosterone. J Clin ndocrinol Metab 48: 139-142.
8. CHAI Z, BRERETON P, SUZUKI T, SASANO H, OBEYESEKERE V, ESCHER G, SAFFERY R, FULLER P, ENRIQUEZ C, KROZOWSKI Z, 2003: 17 beta-hydroxysteroid dehydrogenase type XI localizes to human steroidogenic cells. Endocrinology 144:. 2084-2091.
9. CHARBONNEAU A, THE VL, 2001: Genomic organization of a human 5beta-reductase and its pseudogene and substrate selectivity of the expressed nzyme. Biochim Biophys Acta 1517: 228-235.
10. CONCAS A, FOLLESA P, BARBACCIA ML, PURDY RH, BIGGIO G, 1999: Physiological modulation of GABA(A) receptor plasticity by progesterone metabolites. Eur J Pharmacol 375: 225-235.
11. CROSSLEY KJ, NITSOS I, WALKER DW, LAWRENCE AJ, BEART PM, HIRST JJ, 2003: Steroid-sensitive GABAA receptors in the fetal sheep rain. Neuropharmacology 45: 461-472.
12. DIAZ-ZAGOYA JC, WIEST WG, ARIAS F, 1979:. 20 alpha-Hydroxysteroid oxidoreductase activity and. 20 alpha-dihydroprogesterone concentration in human placenta before and after parturition. Am J Obstet Gynecol 133: 673-676.
13. FUJII E, MELLON SH, 2001: Regulation of uterine gamma-aminobutyric acid(A) receptor subunit expression throughout pregnancy. Endocrinology 42: 1770-1777.
14. FUKUDA M, OKUYAMA T, FURUYA H, 1986: Growth and function of the placenta - with special reference to various enzymes involved in the biosynthesis of steroids in the human placenta. Nippon Sanka Fujinka Gakkai Zasshi 38: 411-416.
15. GILBERT EVANS SE, ROSS LE, SELLERS EM, PURDY RH, ROMACH MK, 2005: 3alpha-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period. Gynecol Endocrinol 21: 268-279.
16. GOLAND RS, WARDLAW SL, STARK RI, BROWN LS JR, FRANTZ AG, 1986: High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy. J Clin Endocrinol Metab 63: 1199-1203.
17. HAWES CS, MCBRIDE MW, PETROPOULOS A, MUELLER UW, SUTCLIFFE RG, 1994: Epitopic heterogeneity of human 3 beta-hydroxysteroid dehydrogenase in villous and extravillous human trophoblast. J Mol Endocrinol 12: 273-281.
18. HE XY, MERZ G, YANG YZ, MEHTA P, SCHULZ H, YANG SY, 2001: Characterization and localization of human type10 17beta-hydroxysteroid ehydrogenase. Eur J Biochem 268: 4899-4907.
19. HE XY, YANG YZ, PEEHL DM, LAUDERDALE A, SCHULZ H, YANG SY, 2003: Oxidative 3alpha-hydroxysteroid dehydrogenase activity of human type 10 17beta-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 87:. 191-198.
20. HERING WJ, IHMSEN H, LANGER H, UHRLAU C, DINKEL M, GEISSLINGER G, SCHUTTLER J, 1996: Pharmacokinetic-pharmacodynamic modeling of the new steroid hypnotic eltanolone in healthy volunteers. Anesthesiology 85: 1290-1299.
21. HILL M, BICIKOVA M, PARIZEK A, HAVLIKOVA H, KLAK J, FAJT T, MELOUN M, CIBULA D, CEGAN A, SULCOVA J, HAMPL R, STARKA L, 2001: Neuroactive steroids, their precursors and polar conjugates during parturition and postpartum in maternal blood: 2. Time profiles of regnanolone isomers. J Steroid Biochem Mol Biol 78: 51-57.
22. HILL M, CIBULA D, HAVLIKOVA H, KANCHEVA L, FAIT T, KANCHEVA R, PARIZEK A, STARKA L, 2007: Circulating levels of pregnanolone isomers during the third trimester of human pregnancy. J Steroid Biochem Mol Biol 105: 166-175.
23. HILL M, PARIZEK A, BICIKOVA M, HAVLIKOVA H, KLAK J, FAIT T, CIBULA D, HAMPL R, CEGAN A, SULCOVA J, STARKA L, 2000: Neuroactive steroids, their precursors, and polar conjugates during parturition and postpartum in maternal and umbilical blood: 1. Identification and simultaneous determination of pregnanolone isomers. J Steroid Biochem Mol Biol 75: 237-244.
24. HILL M, PARIZEK A, CIBULA D, KANCHEVA R, JIRASEK JE, JIRKOVSKA M, VELIKOVA M, KUBATOVA J, KLIMKOVA M, PASKOVA A, ZIZKA Z, KANCHEVA L, KAZIHNITKOVA H, ZAMRAZILOVA L, STARKA L, 2010: Steroid metabolome in fetal and maternal body fluids in human late pregnancy. J Steroid Biochem Mol Biol 122: 114-132.
25. HILL M, PARIZEK A, JIRASEK JE, JIRKOVSKA M, VELIKOVA M, DUSKOVA M, KLIMKOVA M, PASKOVA A, ZIZKA Z, GERMANOVA A, KOUCKY M, KALOUSOVA M, STARKA L, 2010: Is maternal progesterone actually independent of the fetal steroids? Physiol Res 59: 211-224.
26. HILL M, PARIZEK A, KANCHEVA R, DUSKOVA M, VELIKOVA M, KRIZ L, KLIMKOVA M, PASKOVA A, ZIZKA Z, MATUCHA P, MELOUN M, STARKA L, 2010: Steroid metabolome in plasma from the umbilical artery, umbilical vein, maternal cubital vein and in amniotic fluid in normal and preterm labor. J Steroid Biochem Mol Biol 121: 594-610.
27. HIRST JJ, YAWNO T, NGUYEN P, WALKER DW, 2006: Stress in pregnancy activates neurosteroid production in the fetal brain. Neuroendocrinology 84: 264-274.
28. HUANG XF, LUU-THE V, 2000: Molecular characterization of a first human 3(alpha→beta)-hydroxysteroid epimerase. J Biol Chem 275: 29452-9457.
29. INGELMAN-SUNDBERG M, RANE A, GUSTAFASSON JA, 1975: Properties of hydroxylase systems in the human fetal liver active on free and ulfoconjugated steroids. Biochemistry 14: 429-437.
30. ISHIDA T, SEO F, HIRATO K, FUKUDA T, YANAIHARA T, ARAKI H, NAKAYAMA T, 1985: Changes in placental enzymatic activities in relation to estrogen production during pregnancy (in Japanese). Nippon Sanka Fujinka Gakkai Zasshi 37: 547-554.
31. JAFFE RB, LEDGER WJ, 1966: In vivo steroid biogenesis and metabolism in the human term placenta. I. In situ placental perfusion with isotopic regnenolone. Steroids 8: 61-78.
32. JIN Y, DUAN L, LEE SH, KLOOSTERBOER HJ, BLAIR IA, PENNING TM, 2009: Human cytosolic hydroxysteroid dehydrogenases of the aldo-ketoreductase superfamily catalyze reduction of conjugated steroids: implications for phase I and phase II steroid hormone metabolism. J Biol Chem 284: 10013-0022.
33. JIN Y, PENNING TM, 2001: Steroid 5alpha-reductases and 3alpha-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism. Best Pract es Clin Endocrinol Metab 15: 79-94.
34. JIN Y, STAYROOK SE, ALBERT RH, PALACKAL NT, PENNING TM, LEWIS M, 2001: Crystal structure of human type III 3alpha-hydroxysteroid dehydrogenase/bile acid binding protein complexed with NADP(+) and ursodeoxycholate. Biochemistry 40: 10161-10168.
35. KALLELA H, HAASIO J, KORTTILA K, 1994: Comparison of eltanolone and propofol in anesthesia for termination of pregnancy. Anesth Analg 79: 12-516.
36. KANCHEVA R, HILL M, CIBULA D, VCELAKOVA H, KANCHEVA L, VRBIKOVA J, FAIT T, PARIZEK A, STARKA L, 2007: Relationships of circulating pregnanolone isomers and their polar conjugates to the status of sex, menstrual cycle, and pregnancy. J Endocrinol. 195: 67-78.
37. KLAK J, HILL M, PARIZEK A, HAVLIKOVA H, BICIKOVA M, HAMPL R, FAIT T, SULCOVA J, POUZAR V, KANCHEVA R, STARKA L, 2003: Pregnanolone isomers, pregnenolone and their polar conjugates around parturition. Physiol Res 52: 211-221.
38. KNOCK GA, TRIBE RM, HASSONI AA, AARONSON PI, 2001: Modulation of potassium current characteristics in human myometrial smooth muscle by 17beta-estradiol and progesterone. Biol Reprod 64: 1526-1534.
39. KOCHAKIAN CD, 1983: Conversion of testosterone and androstenedione to 5 beta-androstanes by adult male hamster liver cytosol. J Steroid iochem. 19: 1521-1526.
40. KOKSMA JJ, VAN KESTEREN RE, ROSAHL TW, ZWART R, SMIT AB, LUDDENS H, BRUSSAARD AB, 2003: Oxytocin regulates neurosteroid modulation of GABA(A) receptors in supraoptic nucleus around parturition. J Neurosci 23: 788-797.
41. KOMATSUZAKI K, KOSAKI T, HASHINO M, YANAIHARA T, NAKAYAMA T, MORI H, 1987: Metabolism of pregnenolone sulfate in feto-placental unit (in Japanese). Nippon Sanka Fujinka Gakkai Zasshi 39: 1095-1102.
42. KRAZEISEN A, BREITLING R, IMAI K, FRITZ S, MOLLER G, ADAMSKI J, 1999: Determination of cDNA, gene structure and chromosomal localization of the novel human 17beta-hydroxysteroid dehydrogenase type 7(1). FEBS Lett 460: 373-379.
43. KUBLI-GARFIAS C, MEDRANO-CONDE L, BEYER C, BONDANI A, 1979: In vitro inhibition of rat uterine contractility induced by 5 alpha and 5 eta progestins. Steroids 34: 609-617.
44. KUSSIUS CL, KAUR N, POPESCU GK, 2009: Pregnanolone sulfate promotes desensitization of activated NMDA receptors. J Neurosci 29: 6819-827.
45. LACROIX D, SONNIER M, MONCION A, CHERON G, CRESTEIL T, 1997: Expression of CYP3A in the human liver - evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 247: 625-634.
46. LEEDER JS, GAEDIGK R, MARCUCCI KA, GAEDIGK A, VYHLIDAL CA, SCHINDEL BP, PEARCE RE, 2005: Variability of CYP3A7 expression in human fetal liver. J Pharmacol Exp Ther 314: 626-635.
47. LESLIE KK, ZUCKERMAN DJ, SCHRUEFER J, BURCHELL M, SMITH J, ALBERTSON BD, 1994: Oestrogen modulation with parturition in the uman placenta. Placenta 15: 79-88.
48. LI Y, ISOMAA V, PULKKA A, HERVA R, PELTOKETO H, VIHKO P, 2005: Expression of 3beta-hydroxysteroid dehydrogenase type 1, P450 aromatase, and 17beta-hydroxysteroid dehydrogenase types 1, 2, 5 and 7 mRNAs in human early and mid-gestation placentas. Placenta 26: 387-392.
49. LIN SX, SHI R, QIU W, AZZI A, ZHU DW, DABBAGH HA, ZHOU M, 2006: Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5. Mol Cell Endocrinol 248: 38-46.
50. LOCKHART EM, WARNER DS, PEARLSTEIN RD, PENNING DH, MEHRABANI S, BOUSTANY RM, 2002: Allopregnanolone attenuates N-methyl-D-aspartate-induced excitotoxicity and apoptosis in the human NT2 cell line in culture. Neurosci Lett 328: 33-36.
51. LOFGREN M, BACKSTROM T, 1990: Serum concentrations of progesterone and 5 alpha-pregnane-3,20-dione during labor and early post partum. cta Obstet Gynecol Scand 69: 123-126.
52. LOFGREN M, HOLST J, BACKSTROM T, 1992: Effects in vitro of progesterone and two 5 alpha-reduced progestins, 5 alpha-pregnane-3,20-dione and 5 alpha-pregnane-3 alpha-ol-20-one, on contracting human myometrium at term. Acta Obstet Gynecol Scand 71: 28-33.
53. LUISI S, PETRAGLIA F, BENEDETTO C, NAPPI RE, BERNARDI F, FADALTI M, REIS FM, LUISI M, GENAZZANI AR, 2000: Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. J Clin Endocrinol Metab 85: 2429-2433.
54. LUKACIK P, KELLER B, BUNKOCZI G, KAVANAGH KL, LEE WH, ADAMSKI J, OPPERMANN U, 2007: Structural and biochemical characterization of human orphan DHRS10 reveals a novel cytosolic enzyme with steroid dehydrogenase activity. Biochem J 402: 419-427.
55. LUNDGREN P, STROMBERG J, BACKSTROM T, WANG M, 2003: Allopregnanolone-stimulated GABA-mediated chloride ion flux is inhibited by 3beta-hydroxy-5alpha-pregnan-20-one (isoallopregnanolone). Brain Res 982: 45-53.
56. MAGUIRE J, FERANDO I, SIMONSEN C, MODY I, 2009: Excitability changes related to GABAA receptor plasticity during pregnancy. J Neurosci 9: 9592-9601.
57. MAJEWSKA MD, VAUPEL DB, 1991: Steroid control of uterine motility via gamma-aminobutyric acidA receptors in the rabbit: a novel mechanism? J ndocrinol 131: 427-434
58. MALAYEV A, GIBBS TT, FARB DH, 2002: Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids. Br J Pharmacol 135: 901-909.
59. MASON JI, USHIJIMA K, DOODY KM, NAGAI K, NAVILLE D, HEAD JR, MILEWICH L, RAINEY WE, RALPH MM, 1993: Regulation of expression of the 3 beta-hydroxysteroid dehydrogenases of human placenta and fetal adrenal. J Steroid Biochem Mol Biol 47: 151-159.
60. MATHUR RS, LANDGREBE S, WILLIAMSON HO, 1980: Progesterone, 17-hydroxyprogesterone, estradiol, and estriol in late pregnancy and labor. m J Obstet Gynecol 136: 25-27.
61. MATSUURA K, SHIRAISHI H, HARA A, SATO K, DEYASHIKI Y, NINOMIYA M, SAKAI S, 1998: Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity. J Biochem 124: 940-946.
62. MEIKLE AW, STRINGHAM JD, WILSON DE, DOLMAN LI, 1979: Plasma 5 alpha-reduced androgens in men and hirsute women: role of adrenals nd gonads. J Clin Endocrinol Metab 48: 969-975.
63. MELLOR DJ, DIESCH TJ, GUNN AJ, BENNET L, 2005: The importance of 'awareness' for understanding fetal pain. Brain Res Brain Res Rev 49: 55-471.
64. MENG LJ, REYES H, AXELSON M, PALMA J, HERNANDEZ I, RIBALTA J, SJOVALL J, 1997: Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy. Hepatology 26: 1573-1579.
65. MICKAN H, ZANDER J, 1979: Pregnanolones, pregnenolone and progesterone in the human feto-placental circulation at term of pregnancy. J Steroid iochem 11: 1461-1466.
66. MIKI Y, NAKATA T, SUZUKI T, DARNEL AD, MORIYA T, KANEKO C, HIDAKA K, SHIOTSU Y, KUSAKA H, SASANO H, 2002: Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues. J Clin Endocrinol Metab 87: 5760-5768.
67. MILEWICH L, GANT NF, SCHWARZ BE, CHEN GT, MACDONALD PC, 1978: Initiation of human parturition. IX. Progesterone metabolism by placentas of early and late human gestation. Obstet Gynecol 51: 278-280.
68. MILEWICH L, GANT NF, SCHWARZ BE, CHEN GT, MACDONALD PC, 1979: 5 alpha-Reductase activity in human placenta. Am J Obstet ynecol 133: 611-617.
69. MITCHELL BF, MITCHELL JM, CHOWDHURY J, TOUGAS M, ENGELEN SM, SENFF N, HEIJNEN I, MOORE JT, GOODWIN B, WONG S, DAVIDGE ST, 2005: Metabolites of progesterone and the pregnane X receptor: a novel pathway regulating uterine contractility in pregnancy? Am J Obstet Gynecol. 192: 1304-1313; discussion 1313-1315.
70. MITCHELL BF, POWELL WA, 1984: Progesterone production by human fetal membranes: an in vitro incubation system for studying hormone roduction and metabolism. Am J Obstet Gynecol 148: 303-309.
71. MOGHRABI N, HEAD JR, ANDERSSON S, 1997: Cell type-specific expression of 17 beta-hydroxysteroid dehydrogenase type 2 in human placenta nd fetal liver. J Clin Endocrinol Metab 82: 3872-3878.
72. MOSTALLINO MC, SANNA E, CONCAS A, BIGGIO G, FOLLESA P, 2009: Plasticity and function of extrasynaptic GABA(A) receptors during pregnancy and after delivery. Psychoneuroendocrinology 34 (Suppl 1): S74-S83.
73. NAKAYAMA T, 1986: Clinical significance of the feto-placental unit during pregnancy and parturition (in Japanese). Nippon Sanka Fujinka Gakkai asshi 38: 1173-1183.
74. NISHIZAWA M, NAKAJIMA T, YASUDA K, KANZAKI H, SASAGURI Y, WATANABE K, ITO S, 2000: Close kinship of human.1; 20alpha-hydroxysteroid dehydrogenase gene with three aldo-keto reductase genes. Genes Cells 5: 111-125.
75. OKUDA A, OKUDA K, 1984: Purification and characterization of delta 4-3-ketosteroid 5 beta-reductase. J Biol Chem 259: 7519-7524.
76. PARIZEK A, HILL M, KANCHEVA R, HAVLIKOVA H, KANCHEVA L, CINDR J, PASKOVA A, POUZAR V, CERNY I, DRBOHLAV P, HAJEK Z, STARKA L, 2005: Neuroactive pregnanolone isomers during pregnancy. J Clin Endocrinol Metab 90: 395-403.
77. PARK-CHUNG M, MALAYEV A, PURDY RH, GIBBS TT, FARB DH, 1999: Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites. Brain Res 830: 72-87.
78. PARK-CHUNG M, WU FS, PURDY RH, MALAYEV AA, GIBBS TT, FARB DH, 1997: Distinct sites for inverse modulation of N-methyl-D-aspartate receptors by sulfated steroids. Mol Pharmacol 52: 1113-1123.
79. PEARSON MURPHY BE, STEINBERG SI, HU FY, ALLISON CM, 2001: Neuroactive ring A-reduced metabolites of progesterone in human plasma during pregnancy: elevated levels of 5 alpha-dihydroprogesterone in depressed patients during the latter half of pregnancy. J Clin Endocrinol Metab 86: 981-5987.
80. PELTOKETO H, NOKELAINEN P, PIAO YS, VIHKO R, VIHKO P, 1999: Two 17beta-hydroxysteroid dehydrogenases (17HSDs) of estradiol biosynthesis: 17HSD type 1 and type 7. J Steroid Biochem Mol Biol 69: 431-439.
81. PENNING TM, 1999: Molecular determinants of steroid recognition and catalysis in aldo-keto reductases. Lessons from 3alpha-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 69: 211-225.
82. PENNING TM, BURCZYNSKI ME, JEZ JM, HUNG CF, LIN HK, MA H, MOORE M, PALACKAL N, RATNAM K, 2000: Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J 351: 67-77.
83. PENNING TM, BURCZYNSKI ME, JEZ JM, LIN HK, MA H, MOORE M, RATNAM K, PALACKAL N, 2001: Structurefunction aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3). Mol Cell Endocrinol 171: 137-149.
84. PENNING TM, JIN Y, STECKELBROECK S, LANISNIK RIZNER T, LEWIS M, 2004: Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins. Mol Cell Endocrinol 215: 63-72.
85. PENNING TM, STECKELBROECK S, BAUMAN DR, MILLER MW, JIN Y, PEEHL DM, FUNG KM, LIN HK, 2006: Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors. Mol Cell Endocrinol 248: 182-191.
86. PERUSQUIA M, JASSO-KAMEL J, 2001: Influence of 5alpha- and 5beta-reduced progestins on the contractility of isolated human myometrium at erm. Life Sci 68: 2933-2944.
87. POWER ML, SCHULKIN J, 2006: Functions of corticotropin-releasing hormone in anthropoid primates: from brain to placenta. Am J Hum Biol 18: 31-447.
88. PUTNAM CD, BRANN DW, KOLBECK RC, MAHESH VB, 1991: Inhibition of uterine contractility by progesterone and progesterone metabolites: mediation by progesterone and gamma amino butyric acidA receptor systems. Biol Reprod 45: 266-272.
89. RAINEY WE, REHMAN KS, CARR BR, 2004: The human fetal adrenal: making adrenal androgens for placental estrogens. Semin Reprod Med 22: 27-336.
90. RILEY SC, BASSETT NS, BERDUSCO ET, YANG K, LEYSTRA-LANTZ C, LUU-THE V, LABRIE F, CHALLIS JR, 1993: Changes in the abundance of mRNA for type-I 3 beta-hydroxysteroid dehydrogenase/delta 5-->delta 4 isomerase in the human placenta and fetal membranes during pregnancy and labor. Gynecol Obstet Invest 35:. 199-203.
91. RILEY SC, DUPONT E, WALTON JC, LUU-THE V, LABRIE F, PELLETIER G, CHALLIS JR, 1992: Immunohistochemical localization of 3 beta-hydroxy-5-ene-steroid dehydrogenase/delta 5-->delta 4 isomerase in human placenta and fetal membranes throughout gestation. J Clin Endocrinol Metab 75: 56-961.
92. SAKURAI N, MIKI Y, SUZUKI T, WATANABE K, NARITA T, ANDO K, YUNG TM, AOKI D, SASANO H, HANDA H, 2006: Systemic distribution and tissue localizations of human 17beta-hydroxysteroid dehydrogenase type 12. J Steroid Biochem Mol Biol 99: 174-181.
93. SHAFQAT N, MARSCHALL HU, FILLING C, NORDLING E, WU XQ, BJORK L, THYBERG J, MARTENSSON E, SALIM S, JORNVALL H, OPPERMANN U, 2003: Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3alpha/7alpha/7beta/17beta/20beta/21-HSD. Biochem J 376: 49-60.
94. SHAXTED EJ, HEYES VM, WALKER MP, MAYNARD PV, 1982: Umbilical-cord plasma progesterone in term infants delivered by caesarean ection. Br J Obstet Gynaecol 89: 73-76.
95. SHEEHAN PM, 2006: A possible role for progesterone metabolites in human parturition. Aust N Z J Obstet Gynaecol 46: 159-163.
96. SHEEHAN PM, RICE GE, MOSES EK, BRENNECKE SP, 2005: 5 Beta-dihydroprogesterone and steroid 5 beta-reductase decrease in association with human parturition at term. Mol Hum Reprod 11: 495-501.
97. SHIRAISHI H, ISHIKURA S, MATSUURA K, DEYASHIKI Y, NINOMIYA M, SAKAI S, HARA A, 1998: Sequence of the cDNA of a human dihydrodiol dehydrogenase isoform (AKR1C2) and tissue distribution of its mRNA. Biochem J 334: 399-405.
98. SIITERI PK, 2005: The continuing saga of dehydroepiandrosterone (DHEA). J Clin Endocrinol Metab 90: 3795-3796.
99. SIRIANNI R, MAYHEW BA, CARR BR, PARKER CR JR, RAINEY WE, 2005: Corticotropin-releasing hormone (CRH) and urocortin act through type 1 CRH receptors to stimulate dehydroepiandrosterone sulfate production in human fetal adrenal cells. J Clin Endocrinol Metab 90: 5393-5400.
100. SMITH R, MESIANO S, CHAN EC, BROWN S, JAFFE RB, 1998: Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrinol Metab 83: 2916-2920.
101. SMITH R, SMITH JI, SHEN X, ENGEL PJ, BOWMAN ME, MCGRATH SA, BISITS AM, MCELDUFF P, GILES WB, SMITH DW, 2009: Patterns of plasma corticotropin-releasing hormone, progesterone, estradiol, and estriol change and the onset of human labor. J Clin Endocrinol Metab 94:. 066-2074.
102. STECKELBROECK S, JIN Y, GOPISHETTY S, OYESANMI B, PENNING TM, 2004: Human cytosolic 3alphahydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3betahydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. J iol Chem 279: 10784-10795.
103. STOA KF, BESSESEN A, 1975: Identification and quantitation of 5alpha-pregnanedione in human pregnancy plasma. J Steroid Biochem 6: 21-25.
104. TAKEYAMA J, SASANO H, SUZUKI T, IINUMA K, NAGURA H, ANDERSSON S, 1998: 17Beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta: an immunohistochemical study with correlation to placental development. J Clin Endocrinol Metab 83: 3710-3715.
105. TODOROVIC SM, PATHIRATHNA S, BRIMELOW BC, JAGODIC MM, KO SH, JIANG X, NILSSON KR, ZORUMSKI CF, COVEY DF, JEVTOVIC-TODOROVIC V, 2004: 5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo. Mol Pharmacol 66: 1223-1235.
106. TORN S, NOKELAINEN P, KURKELA R, PULKKA A, MENJIVAR M, GHOSH S, COCA-PRADOS M, PELTOKETO H, ISOMAA V, VIHKO P, 2003: Production, purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7. Biochem Biophys es Commun 305: 37-45.
107. TURKMEN S, LOFGREN M, BIRZNIECE V, BACKSTROM T, JOHANSSON IM, 2006: Tolerance development to Morris water maze test impairments induced by acute allopregnanolone. Neuroscience 139: 651-659.
108. TURNBULL AC, PATTEN PT, FLINT AP, KEIRSE MJ, JEREMY JY, ANDERSON AB, 1974: Significant fall in progesterone and rise in oestradiol levels in human peripheral plasma before onset of labour. Lancet 1: 101-103.
109. USAMI N, YAMAMOTO T, SHINTANI S, ISHIKURA S, HIGAKI Y, KATAGIRI Y, HARA A, 2002: Substrate specificity of human 3(20)alpha-hydroxysteroid dehydrogenase for neurosteroids and its inhibition by benzodiazepines. Biol Pharm Bull 25: 441-445.
110. VU TT, HIRST JJ, STARK M, WRIGHT IM, PALLISER HK, HODYL N, CLIFTON VL, 2009: Changes in human placental 5alpha-reductase isoenzyme expression with advancing gestation: effects of fetal sex and glucocorticoid exposure. Reprod Fertil Dev 21: 599-607.
111. WALSH SW, 1988: Progesterone and estradiol production by normal and preeclamptic placentas. Obstet Gynecol 71: 222-226.
112. WATANABE H, HIRATO K, HASHINO M, KOSAKI T, KIMURA T, NAKAYAMA T, YANAIHARA T, 1990: Effects of DHA-S on placental 3 beta-hydroxysteroid dehydrogenase activity, progesterone and. 20 alphadihydroprogesterone concentrations in placenta and serum. Endocrinol Jpn 37: 69-77.
113. WEAVER CE, LAND MB, PURDY RH, RICHARDS KG, GIBBS TT, FARB DH, 2000: Geometry and charge determine pharmacological effects of steroids on N-methyl-D-aspartate receptor-induced Ca(2+) accumulation and cell death. J Pharmacol Exp Ther 293: 747-754.
114. YAWNO T, HIRST JJ, CASTILLO-MELENDEZ M, WALKER DW, 2009: Role of neurosteroids in regulating cell death and proliferation in the late estation fetal brain. Neuroscience 163: 838-847.
115. YOSHIHARA S, MORIMOTO H, OHORI M, YAMADA Y, ABE T, ARISAKA O, 2005: A neuroactive steroid, allotetrahydrocorticosterone inhibits sensory nerves activation in guinea-pig airways. Neurosci Res 53: 210-215.